BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kiraly P, Groznik AL, Valentinčič NV, Mekjavić PJ, Urbančič M, Ocvirk J, Mesti T. Choroidal thickening with serous retinal detachment in BRAF/MEK inhibitor-induced uveitis: A case report. World J Clin Cases 2022; 10(19): 6536-6542 [PMID: 35979276 DOI: 10.12998/wjcc.v10.i19.6536]
URL: https://www.wjgnet.com/2307-8960/full/v10/i19/6536.htm
Number Citing Articles
1
AntineoplasticsReactions Weekly 2022; 1921(1): 39 doi: 10.1007/s40278-022-22033-0
2
Peter Kiraly, M. Dominik Fischer. Cystoid Macular Oedema in a Patient Treated with STING Agonist and Ezabenlimab for Disseminated MelanomaOphthalmology and Therapy 2024;  doi: 10.1007/s40123-024-00911-4
3
Shuohan Huang, Zihan Guo, Mengmeng Wang, Youjun She, Xuan Ye, Qing Zhai, Jiyong Liu, Qiong Du. Ocular adverse events associated with BRAF and MEK inhibitor combination therapy: a pharmacovigilance disproportionality analysis of the FDA adverse event reporting systemExpert Opinion on Drug Safety 2023; 22(2): 175 doi: 10.1080/14740338.2023.2189235